Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants
about
Emerging Threats in Antifungal-Resistant Fungal PathogensA functional variomics tool for discovering drug-resistance genes and drug targets.Sterol methyltransferase 1 controls the level of cholesterol in plantsChanges in the Sterol Composition of the Plasma Membrane Affect Membrane Potential, Salt Tolerance and the Activity of Multidrug Resistance Pumps in Saccharomyces cerevisiaeWidespread Genetic Incompatibilities between First-Step Mutations during Parallel Adaptation of Saccharomyces cerevisiae to a Common EnvironmentAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisCandida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target siteTranscriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.Comparative genomics allowed the identification of drug targets against human fungal pathogens.Calcineurin is essential for survival during membrane stress in Candida albicans.Drug strategies targeting CYP51 in neglected tropical diseasesErgosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae.Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.Transcriptional profiling analysis of Penicillium digitatum, the causal agent of citrus green mold, unravels an inhibited ergosterol biosynthesis pathway in response to citral.ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantRapid Evaporative Ionisation Mass Spectrometry (REIMS) Provides Accurate Direct from Culture Species Identification within the Genus CandidaParallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast.The synthesis, regulation, and functions of sterols in Candida albicans: Well-known but still lots to learn.Control of Candida albicans morphology and pathogenicity by post-transcriptional mechanisms.Drug susceptibilities of yeast cells are affected by membrane lipid composition.Antifungal resistance and new strategies to control fungal infections.Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity.Identification and Mode of Action of a Plant Natural Product Targeting Human Fungal Pathogens.A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae.Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.Effect of Cinnamaldehyde and Citral Combination on Transcriptional Profile, Growth, Oxidative Damage and Patulin Biosynthesis of Penicillium expansum.Candida albicans gains azole resistance by altering sphingolipid composition
P2860
Q26750816-AD23A85B-59A1-4AF7-98F7-A1336258FDE9Q27932829-FA06392E-EA1B-4DA3-871B-77890C02FFB5Q28344339-4EF638DA-5A15-4471-9351-0AB81C692F01Q28548587-5477D453-C4F0-400C-B5A9-F0EA045818F6Q28818537-1369A047-0633-4822-8E20-74DC65A0CA0AQ28818603-7888752D-CE0F-4D8B-8B3E-FCEC5D91DCF2Q30827584-2A0B3F82-8891-4BDF-A762-BCA87DC75FF5Q33261315-16222403-EE5B-42E1-92B0-7C579A415A6CQ33805404-1F07E39F-17D5-4948-8259-5923CC7D8DF9Q34085830-64613D99-8A87-4B7E-9D94-F051B5F8919FQ34622554-127838B7-76D9-425F-B97D-F55F6997476BQ34735206-CD5A1D2E-2AD5-40ED-9550-AE20428E801FQ34973741-1F75F405-8C7C-4967-82F1-8AEBFAC0FA65Q35165864-69D12004-B44C-4AF6-B200-AC818E29C138Q36101724-0219210F-918A-4409-B818-2B0D4C69D2F2Q36106885-18741959-40EC-47D1-AD19-A95CF98976D7Q36141819-7C5BEE27-CE49-4AA2-8EAD-A41403DBD934Q36191450-E07FD2CD-7D24-483F-A384-1A808388D82AQ36198245-78852C89-D681-412A-AFEA-A0DF06BC0C20Q37189877-9F03FAD1-6322-4BAA-90B0-AB3F51BF78D6Q38867619-43A8B696-2524-4B04-BEA2-EB31C7482583Q39671060-44E02CAD-18D7-4654-B71D-135879B86F33Q39751373-BEB4B188-1F86-46AD-A6B4-2AB37D936E77Q39955972-A73A7D9E-893C-44D0-8C8C-CCE1A9A89718Q40148508-0810DE32-CC2E-4694-A4D8-85080C15BF61Q41774705-F8769187-027A-413B-82A4-846AFA10C720Q41816687-8BF36CF6-50B8-4A52-B44A-BF17A9DA96DEQ42477429-59D09D70-0CEB-4A21-BC7D-49874CF8309FQ42948674-9E5BF24A-EDDD-48EE-8E7E-D35C87989465Q46257698-74701AF1-0B6A-42B6-BE14-821E639F5941Q55259114-83820ED7-B9E9-40A8-A413-85D617875C0FQ58105713-9B9A850A-09A2-43A4-9EBC-B30DDDB854B5
P2860
Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: drug susceptibility studies in erg6 mutants
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Sequencing, disruption, and ch ...... bility studies in erg6 mutants
@en
Sequencing, disruption, and ch ...... ility studies in erg6 mutants.
@nl
type
label
Sequencing, disruption, and ch ...... bility studies in erg6 mutants
@en
Sequencing, disruption, and ch ...... ility studies in erg6 mutants.
@nl
prefLabel
Sequencing, disruption, and ch ...... bility studies in erg6 mutants
@en
Sequencing, disruption, and ch ...... ility studies in erg6 mutants.
@nl
P2093
P2860
P356
P1476
Sequencing, disruption, and ch ...... bility studies in erg6 mutants
@en
P2093
K L Jensen-Pergakes
M A Kennedy
P2860
P304
P356
10.1128/AAC.42.5.1160
P407
P577
1998-05-01T00:00:00Z